Filing Details

Accession Number:
0001209191-16-114141
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-04-13 18:32:24
Reporting Period:
2016-04-11
Filing Date:
2016-04-13
Accepted Time:
2016-04-13 18:32:24
Original Submission Date:
2016-04-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339970 Atyr Pharma Inc LIFE () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236447 Paul Schimmel 3545 John Hopkins Court, Suite #250
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-11 5,259 $3.59 17,831 No 4 P Direct
Common Stock Acquisiton 2016-04-11 5,300 $3.45 211,481 No 4 P Indirect See Footnote
Common Stock Acquisiton 2016-04-11 22,100 $3.59 233,581 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 634,242 Indirect See Footnote
Footnotes
  1. Represents the weighted average price for the shares. The shares were purchased at prices ranging from $3.58 per share to $3.60 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
  2. Represents the weighted average price for the shares. The shares were purchased at prices ranging from $3.44 per share to $3.45 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
  3. Certain of the shares of Common stock were inadvertently reported as being directly held by the Reporting Person rather than indirectly held by the Paul R. Schimmel Prototype PSP
  4. These shares are owned directly by Paul R. Schimmel Prototype PSP. The Reporting Person is the trustee of the Paul R. Schimmel Prototype PSP.
  5. These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U.A Dtd 9/6/2000.